Ceribell │ Point-of-Care EEG
Regional Director
Chicago, IL | $200K - $200K
- 51-200 employees
- Medical Diagnostics, Technology, Medical Devices, Healthcare, Digital Health, Hospital & Health Care, Emergency Medicine, Neurology, Neurodiagnostics, Hospital and Health Care
- Privately Held
- Founded: 2014
- Last round: Series C
- Last round: US$ 50.0M
- Sunnyvale, California
- Company Specialties:
neurodiagnostics, Brain waves, Electroencephalography (EEG), Epilepsy, Seizures, Coma, Brain monitor, Point-of-care, Healthcare, Technology, disruptive, and Rapid EEG
Company information
Ceribell is a fast growing venture-backed medical device start-up company founded by two faculty members at Stanford University. Our primary mission is to improve neurological care for emergency and ICU patients. Ceribell is focused on making EEG widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizures. The System can be set up by any healthcare provider within minutes. Now with Clarity, Ceribell offers 24/7 continuous bedside EEG monitoring and alert.
